Etanercept Treatment in Patients With Moderate to Severe Plaque Psoriasis Who Lost Response to Adalimumab
Public ClinicalTrials.gov record NCT01543204. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.
Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.
Official title
Open Label Study to Evaluate the Efficacy of Etanercept Treatment in Subjects With Moderate to Severe Plaque Psoriasis Who Have Lost a Satisfactory Response to Adalimumab
Brief summary
Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.
This study will evaluate the efficacy of etanercept in patients with plaque psoriasis who have lost a satisfactory response to adalimumab.
Study identification
- NCT ID
- NCT01543204
- Recruitment status
- Terminated
- Study type
- Interventional
- Phase
- Phase 4
- Enrollment
- 64 participants
Conditions and interventions
Conditions
Eligibility (public fields only)
- Age range
- 18 Years and older
- Sex
- All
- Healthy volunteers
- Healthy volunteers not accepted
This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.
Study timeline
- Start date
- Jan 31, 2012
- Primary completion
- May 28, 2015
- Completion
- May 28, 2015
- Last update posted
- Dec 28, 2017
2012 – 2015
United States locations
- U.S. sites
- 42
- U.S. states
- 23
- U.S. cities
- 41
| Facility | City | State | ZIP | Site status |
|---|---|---|---|---|
| Research Site | Birmingham | Alabama | 35205 | — |
| Research Site | Mobile | Alabama | 36609 | — |
| Research Site | Phoenix | Arizona | 85044 | — |
| Research Site | Bakersfield | California | 93309 | — |
| Research Site | Encino | California | 91436 | — |
| Research Site | Irvine | California | 92697 | — |
| Research Site | Los Angeles | California | 90045 | — |
| Research Site | Sacramento | California | 95816 | — |
| Research Site | San Francisco | California | 94118 | — |
| Research Site | San Ramon | California | 94583 | — |
| Research Site | Santa Monica | California | 90404 | — |
| Research Site | Denver | Colorado | 80220 | — |
| Research Site | Farmington | Connecticut | 06030 | — |
| Research Site | Jacksonville | Florida | 32204 | — |
| Research Site | Miami | Florida | 33136 | — |
| Research Site | St. Petersburg | Florida | 33708 | — |
| Research Site | Tampa | Florida | 33607 | — |
| Research Site | Tampa | Florida | 33609 | — |
| Research Site | Atlanta | Georgia | 30342 | — |
| Research Site | Macon | Georgia | 31217 | — |
| Research Site | Skokie | Illinois | 60077 | — |
| Research Site | New Albany | Indiana | 47150 | — |
| Research Site | Plainfield | Indiana | 46168 | — |
| Research Site | Louisville | Kentucky | 40202 | — |
| Research Site | New Orleans | Louisiana | 70112 | — |
| Research Site | Boston | Massachusetts | 02115 | — |
| Research Site | St Louis | Missouri | 63117 | — |
| Research Site | Omaha | Nebraska | 68144 | — |
| Research Site | East Windsor | New Jersey | 08520 | — |
| Research Site | Verona | New Jersey | 07044 | — |
| Research Site | Rochester | New York | 14625 | — |
| Research Site | Pittsburgh | Pennsylvania | 15213 | — |
| Research Site | Plymouth Meeting | Pennsylvania | 19462 | — |
| Research Site | Johnston | Rhode Island | 02919 | — |
| Research Site | Charleston | South Carolina | 29414 | — |
| Research Site | Bartlett | Tennessee | 38134 | — |
| Research Site | Knoxville | Tennessee | 37917 | — |
| Research Site | Nashville | Tennessee | 37215 | — |
| Research Site | Dallas | Texas | 75231 | — |
| Research Site | Houston | Texas | 77004 | — |
| Research Site | Norfolk | Virginia | 23507 | — |
| Research Site | Walla Walla | Washington | 99362 | — |
Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.
Non-U.S. locations
This page focuses on the U.S. directory. The official record also lists 5 non-U.S. sites.
About this trial record page
- What this page shows
- Public field values for ClinicalTrials.gov record NCT01543204, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
- What this page does not do
- No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
- Where the data comes from
- Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
- Last refresh
- Last update posted Dec 28, 2017 · Synced Sep 12, 2026
Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.
Open the official record
The complete protocol, eligibility criteria, and contact information for NCT01543204 live on ClinicalTrials.gov.